Effect of insulin Secretagogues on Major Cardiovascular events and all-cause mortality: a meta-analysis of randomized controlled trials
In 2019, the Italian Society of Diabetology and the Italian Association of Clinical Diabetologists nominated an expert panel to develop guidelines for drug treatment of type 2 diabetes. This expert panel, after identifying the effects of glucose-lowering agents on major adverse cardiovascular events (MACEs) and all-cause mortality as critical outcomes, decided to perform a systematic review and meta-analysis on the effect of insulin secretagogues (sulfonylureas and glinides) with this respect.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: Edoardo Mannucci, Matteo Monami, Riccardo Candido, Basilio Pintaudi, Giovanni Targher, SID-AMD joint panel for Italian Guidelines on Treatment of Type 2 Diabetes. The Panel is composed of Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Insulin | Italy Health | Nutrition